Raymond James Rates American Healthcare REIT (AHR) Strong Buy
Raymond James has reiterated its Strong Buy rating on American Healthcare REIT, Inc. with a price target of $62, a 16.77% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Raymond James rated American Healthcare REIT, Inc. ($AHR) "Strong Buy" with a $62 price target on October 13, 2026.
Since the rating, $AHR is up 1.3% to date (from the $52.53 close on Oct 13, 2026).
AHR
American Healthcare REIT, Inc.
Key Points
- On October 13, 2026, Raymond James reiterated its Strong Buy rating on American Healthcare REIT, Inc. and set a price target of $62.
- Raymond James's $62 price target implies 16.77% upside from American Healthcare REIT, Inc.'s ($AHR) current $53.09 share price.
- The stock closed at $52.53 on the same day and is now trading around $53.09, about 1.1% above its previous close.
- American Healthcare REIT has a market cap of approximately $11.6 billion and a forward P/E ratio of 53.8.
Get $AHR trade alerts by text
We text you when insiders, Congress or big funds trade $AHR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated American Healthcare REIT, Inc. alert may contain errors. Disclosures
Raymond James has reiterated its Strong Buy rating on American Healthcare REIT, Inc. (AHR) and set a price target of $62 as of October 13, 2026. The stock closed at $52.53 on that day and is currently trading around $53.09, reflecting a 1.1% increase since then.
Raymond James vs. the S&P 500
Hypothetical returns from Raymond James's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in American Healthcare REIT, Inc.
Blackrock Inc. reduced its stake by 2,894,125 shares, ending with 25,845,948 shares valued at about $1.38 billion. Vanguard Portfolio Management LLC added 851,352 shares, bringing its total to 16,975,438 shares worth approximately $904.0 million. Vanguard Capital Management LLC increased its holdings by 1,002,723 shares, totaling 9,201,599 shares valued at about $490.0 million. State Street Corporation trimmed its position by 499,216 shares, ending with 9,046,025 shares worth around $481.7 million. Principal Financial Group, Inc. grew its stake by 1,494,973 shares, bringing its total to 8,917,875 shares valued at about $474.9 million.
American Healthcare REIT, Inc. Stock Up 0.2%
Currently, AHR trades above its 52-week low of $41.67 but below its 52-week high of $58.70. The stock is recently above its 200-day moving average of $51.16, indicating some upward momentum. However, it remains below the mean analyst target price of $63.69, suggesting potential upside.
$AHR price target
American Healthcare REIT, Inc. daily closes and this analyst's $62 target. Not advice.
Recent Earnings
American Healthcare REIT reported trailing twelve-month revenue of approximately $2.5 billion, with a year-over-year revenue growth of 24.7%. The company's net margin stands at 4.8%, and it has a return on equity of 4.0%. The next earnings report is scheduled for November 5, 2026.
Insider Buying and Selling at American Healthcare REIT, Inc.
Insider activity includes Mark E. Foster, General Counsel, who sold 2,500 shares at an average price of $48.58 on June 24, 2026, totaling about $121,450. CFO Brian Scott Peay sold 25,000 shares at an average price of $50.70 on June 26, 2026, valued at around $1.27 million. Mark E. Foster also sold 2,000 shares at $55.39 on September 1, 2026, for about $110,780, and another 1,500 shares at $52.06 on September 25, 2026, totaling $78,090.
Analysts Set New Price Targets
On October 13, 2026, UBS maintained its Buy rating on AHR with a price target of $62.00. Barclays also maintained its Overweight rating with a target of $60.00, down from $66.00. Scotiabank kept its Sector Outperform rating with a target of $62.00, previously $56.00. The consensus among analysts is a Strong Buy with a mean price target of $63.69 based on 16 opinions.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc., based in Irvine, California, is a self-managed real estate investment trust (REIT) that owns and manages a diversified portfolio of clinical healthcare properties. Its focus includes senior housing, skilled nursing facilities, and outpatient medical buildings across the U.S., U.K., and Isle of Man.
Bottom Line
Investors will be looking forward to the upcoming earnings report on November 5, 2026, for more insights into the company's performance. Raymond James’ reiteration of a Strong Buy rating suggests confidence in the company's growth potential amid its recent performance.
Related Filing Alerts
Source: Raymond James's rating change on $AHR (Oct 13, 2026). Written by software, not financial advice. How we make alerts